Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR -, HER2 -, MET - and ROS1 -Alterated Lung Adenocarcinoma.
Saved in:
| Title: | Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR -, HER2 -, MET - and ROS1 -Alterated Lung Adenocarcinoma. |
|---|---|
| Authors: | Plomer, Eva1 (AUTHOR) eva.plomer@kssg.ch, Früh, Martin1,2 (AUTHOR) martin.frueh@kssg.ch, Lauber, Arno3 (AUTHOR) arno.lauber@kssg.ch, Demmer, Izadora4 (AUTHOR) izadora.demmerbuchs@kssg.ch, Jochum, Wolfram4 (AUTHOR) wolfram.jochum@kssg.ch, Koster, Kira-Lee1 (AUTHOR) kira-lee.koster@kssg.ch |
| Source: | International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p5698. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms25115698 |
